IP Library Granted Patent US 10,328,113
Granted Patent B2
US 10,328,113 · App. 13/562,520 · Granted Jun 25, 2019

Method for preventing or treating an allergic disease using extract from illicium verum

Inventors: TaeSook Yoon (Seoul, KR); Yoon-Young Sung (Daejeon, KR); Won-Kyung Yang (Daegu, KR); Ho Kyoung Kim (Daejeon, KR)
Assignee: Korea Institute of Oriental Medicine
A61K36/79A23L33/105A61K8/97A61K9/0014A61K47/10A61Q19/00A61K2800/75
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,328,113
App. No.
13/562,520
Granted
Jun 25, 2019
Kind
B2
Abstract

The present invention provides a method for preventing or treating an allergic disease, comprising administering to a subject a composition comprising an extract from Illicium verum as an active ingredient. The extract from Illicium verum of the present invention reduces the secretion amount of increased histamine by compound 48/80 and the production amount of the increased allergenic cytokines (TNF-α, IL-4 and IL-8) by PMA and A23187. The Illicium verum extract of the present invention reduces edema, dermatitis and IgE concentration of serum in atopic dermatitis mouse model. The Illicium verum extract of the present invention may be efficiently use for prevention, improvement or treatment of various allergic disease such as edema, hypersensitivity, contact dermatitis, atopic dermatitis, skin allergy, asthma or urticaria as pharmaceutical compositions, skin external applications, cosmetic compositions or food compositions.

Claims (20)

1. A method for treating an allergic disease, comprising administering to the skin of a subject a composition comprising a solvent extract from Illicium verum as the only active ingredient against allergic disease of the composition.

2. The method according to claim 1 , wherein the allergic disease is selected from the group consisting of edema, anaphylaxis, allergic rhinitis, asthma, allergic conjunctivitis, allergic dermatitis, atopic dermatitis, contact dermatitis, urticaria, pruritus, insect allergy, alimentary allergy, and drug allergy.

3. The method according to claim 1 , wherein the composition is a cosmetic composition.

4. The method according to claim 1 , wherein the allergic disease is edema.

5. The method according to claim 1 , wherein the allergic disease is anaphylaxis.

6. The method according to claim 1 , wherein the allergic disease is allergic rhinitis.

7. The method according to claim 1 , wherein the allergic disease is asthma.

8. The method according to claim 1 , wherein the allergic disease is allergic conjunctivitis.

9. The method according to claim 1 , wherein the allergic disease is allergic dermatitis.

10. The method according to claim 1 , wherein the allergic disease is atopic dermatitis.

11. The method according to claim 1 , wherein the allergic disease is contact dermatitis.

12. The method according to claim 1 , wherein the allergic disease is urticaria.

13. The method according to claim 1 , wherein the allergic disease is pruritus.

14. The method according to claim 1 , wherein the allergic disease is insect allergy.

15. The method according to claim 1 , wherein the allergic disease is alimentary allergy.

16. The method according to claim 1 , wherein the allergic disease is drug allergy.

17. The method according to claim 1 , wherein the composition is in the form of a paste.

18. The method according to claim 1 , wherein the composition is in the form of a gel.

19. The method according to claim 1 , wherein the extract is obtained using a solvent selected from the group consisting of (a) water, (b) C1-C4 anhydrous or hydrous lower alcohol, (c) a mixture solvent of the lower alcohol with water, (d) acetone, (e) ethylacetate, (f) chloroform, (g) 1,3-butylene glycol, (h) hexane, (i) diethyl ether, and (j) butyl acetate.

20. The method according to claim 19 , wherein the C1-C4 anhydrous or hydrous lower alcohol is selected from the group consisting of methanol, ethanol, propanol, butanol, n-propanol, isopropanol, and n-butanol.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2012
From: YOON, TAESOOK; SUNG, YOON-YOUNG; YANG, WON-KYUNG; KIM, HO KYOUNG
To: KOREA INSTITUTE OF ORIENTAL MEDICINE
Reel/Frame 028685/0554 →
Continuity (1)
Related Publication 20140037761A1 · Feb 6, 2014